Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss KALV - KalVista Pharmaceuticals, Inc.
-3.49 M
LAST VALUE
4.95%
2 YEAR CAGR
-12.61%
5 YEAR CAGR
-22.97%
10 YEAR CAGR